Want to join the conversation?
$JNJ said that its operating margin improvements for 2016 are on track to meet the expectations laid out in the guidance of more than 200 BP improvement YoverY. Also in medical device business, the company is seeing continued signs of improvement and the restructuring activities in the business are on track.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)